期刊文献+

盐酸丙酰左卡尼汀有关物质的合成研究

Preparation of the related substances ofpropionyl levocarnitine hydrochloride
下载PDF
导出
摘要 目的为了更好的控制盐酸丙酰左卡尼汀产品的质量,建立健全盐酸丙酰左卡尼汀原料药的质量标准。方法根据盐酸丙酰左卡尼汀的合成路线及工艺条件,分析并合成了原料药中可能存在的4种有关物质并经1H-NMR、MS等进行了结构确证。结果合成了盐酸丙酰左卡尼汀中存在的4种有关物质,为以后合成建立药物质量标准所需对照品提供了参考。结论各个有关物质的合成方法所用起始原料经济、简单易得,收率较高,所得产品纯度较高,合成工艺简便、条件温和、易于操作,合成路线可行。 Objective To establish and improve the quality standards for propionyl levocanrnitine hydrochloride API and to control the quality of the drug.Methods Four related substances that might exist in the API were synthesized according to the technologic route and conditions of the synthesis,and the structures were confirmed by 1 H -NMR and MS.Results These substances provided refer-ence for the synthesis of reference substances needed for the quality standards of the drug.Conclusions The raw materials for the syn-thesis were available with high coefficient of recovery.The product had high purity.The processing was simple,operative and feasible.
作者 张立
出处 《安徽医药》 CAS 2016年第1期43-45,共3页 Anhui Medical and Pharmaceutical Journal
关键词 盐酸丙酰左卡尼汀 有关物质 合成 propionyl L -carnitine hydrochloride related substance synthesis
  • 相关文献

参考文献7

二级参考文献46

  • 1Loffredo L, Pignatelli P, Cangemi R, et al. Imbalance between nitric oxide generation and oxidative stress in patients with peripheral arterial disease: effect of an antioxidant treatment[J].J Vasc Surg, 2006,44(3):525-530.
  • 2Allegra C, Antignani PL, Schachter I, et al. Propionyl-L-carnitine in Leriche-Fontaine stage Ⅱ peripheral arterial obstructive disease[J]. Ann Vasc Surg,2008,22(4):552-558.
  • 3Hiatt WR, Regensteiner JG, Creager MA,et al. Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication[J].Am J Med,2001,110(8):616-622.
  • 4Barker GA, Green S, Askew CD, et al. Effect of propionyl-L-camitine on exercise performance in peripheral arterial disease[J]. Med Sci Sports Exert, 2001,33(9): 1415 - 1422.
  • 5Smith WA, Fry AC, Tscbume LC, et al. Effect of glycine propionyl- L-camitine on aerobic and anaerobic exercise performance[J]. Int J Sport Nutr Exerc Metab, 2008,18(1): 19-36.
  • 6Riccioni C, Sarcinella R, Palermo G, et al. Evaluation of the efficacy of propionyl-L-carnitine versus pulsed muscular compressions in diabetic and non-diabetic patients affected by obliterating arteriopathy Leriehe stage Ⅱ[J].Int Angiol, 2008,27(3):253-259.
  • 7zzollini N, Cugini D, Cassis P, et al. Propionyl-L-carnitine prevents early graft dysfunction in allogeneic rat kidney transplantation[J]. Kidney Int, 2008,74(11): 1420-1428.
  • 8Origlia N, Migliori M, Panichi V, et al. Protective effect of L-propionylcamitine in chronic cyclosporine-a induced nephrotoxicity[J]. Biorned Pharmacother, 2006,60(2):77-81.
  • 9Aleisa AM, Al-Majed AA, Al-Yahya AA, et al. Reversal of cisplatininduced carnitine deficiency and energy starvation by propionyl- L-carnitine in rat kidney tissues.[J] Clin Exp Pharmacol Physiol, 2007,34(12): 1252-1259.
  • 10Broderick TL.ATP production and TCA activity are stimulated by propionyl-L-carnitine in the diabetic rat heart[J]. Drugs R D, 2008,9(2):83-91.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部